BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16770260)

  • 21. Intravitreal triamcinolone acetonide for the management of papillophlebitis and associated macular edema.
    Chang YC; Wu WC
    Int Ophthalmol; 2008 Aug; 28(4):291-6. PubMed ID: 17701380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve.
    Finger PT; Chin KJ; Tena LB
    Ophthalmology; 2012 Feb; 119(2):415-22. PubMed ID: 22133796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plaque radiotherapy for juxtapapillary choroidal melanoma overhanging the optic disc in 141 consecutive patients.
    Sagoo MS; Shields CL; Mashayekhi A; Freire J; Emrich J; Reiff J; Komarnicky L; Shields JA
    Arch Ophthalmol; 2008 Nov; 126(11):1515-22. PubMed ID: 19001218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiangiogenic or Corticosteroid Treatment in Patients With Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma.
    Seibel I; Hager A; Riechardt AI; Davids AM; Böker A; Joussen AM
    Am J Ophthalmol; 2016 Aug; 168():31-39. PubMed ID: 27163234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal triamcinolone acetonide for diabetic macular edema.
    Chieh JJ; Roth DB; Liu M; Belmont J; Nelson M; Regillo C; Martidis A
    Retina; 2005; 25(7):828-34. PubMed ID: 16205559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
    Park CH; Jaffe GJ; Fekrat S
    Am J Ophthalmol; 2003 Sep; 136(3):419-25. PubMed ID: 12967793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study.
    Ip M; Kahana A; Altaweel M
    Semin Ophthalmol; 2003 Jun; 18(2):67-73. PubMed ID: 14566625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma.
    Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; O'Regan M; Shields JA
    Retina; 2008; 28(7):987-95. PubMed ID: 18698302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periocular triamcinolone for prevention of macular edema after plaque radiotherapy of uveal melanoma: a randomized controlled trial.
    Horgan N; Shields CL; Mashayekhi A; Salazar PF; Materin MA; O'Regan M; Shields JA
    Ophthalmology; 2009 Jul; 116(7):1383-90. PubMed ID: 19481812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric and late radiation toxicity comparison between iodine-125 brachytherapy and stereotactic radiation therapy for juxtapapillary choroidal melanoma.
    Krema H; Heydarian M; Beiki-Ardakani A; Weisbrod D; Xu W; Laperriere NJ; Sahgal A
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):510-5. PubMed ID: 23507292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
    Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
    Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion.
    Bashshur ZF; Ma'luf RN; Allam S; Jurdi FA; Haddad RS; Noureddin BN
    Arch Ophthalmol; 2004 Aug; 122(8):1137-40. PubMed ID: 15302653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases.
    Sagoo MS; Shields CL; Emrich J; Mashayekhi A; Komarnicky L; Shields JA
    JAMA Ophthalmol; 2014 Jun; 132(6):697-702. PubMed ID: 24652552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.
    Arevalo JF; Sanchez JG; Garcia RA; Wu L; Berrocal MH; Rodriguez FJ; Rodríguez A; Novoa LA; Garcia-Amaris R
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1673-80. PubMed ID: 17619895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ; Zaheer I; Karia N
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion.
    Cekiç O; Chang S; Tseng JJ; Barile GR; Del Priore LV; Weissman H; Schiff WM; Ober MD
    Retina; 2005; 25(7):851-5. PubMed ID: 16205563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma.
    Shah SU; Shields CL; Bianciotto CG; Iturralde J; Al-Dahmash SA; Say EAT; Badal J; Mashayekhi A; Shields JA
    Ophthalmology; 2014 Jan; 121(1):269-275. PubMed ID: 24139123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton beam therapy of parapapillary choroidal melanoma.
    Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
    Williamson TH; O'Donnell A
    Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.